Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2025-06-24 Board/Management Inform…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Zgłoszenie kandydata do Rady Nadzorczej Spółki / Submission of Candidate to the Company's Supervisory Board - Content (PL)
Board/Management Information Classification · 95% confidence The document is very short (937 characters) and announces that the Management Board of Selvita S.A. received a nomination from a major shareholder (Nationale-Nederlanden Otwarty Fundusz Emerytalny) for a candidate (Mr. Jacek Osowski) to the Supervisory Board, in connection with the upcoming Annual General Meeting (Zwyczajne Walne Zgromadzenie) scheduled for June 30, 2025. The text explicitly states that the content of the shareholder's request is attached ('Treść wniosku akcjonariusza stanowi załącznik do niniejszego raportu'). This structure—a brief announcement stating that detailed material is attached or available—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the core subject is the nomination of a board member, which relates to management/governance, but the document itself is merely an announcement of the attached nomination request, RPA is a strong candidate if the attachment contains the actual nomination details. However, the nomination of a board member is a specific event. Given the context of an AGM where board members are appointed, and a major shareholder is nominating a candidate, this is highly relevant to Board/Management Information (MANG) or potentially AGM Information (AGM-R). Since the document is an announcement about a nomination for the Supervisory Board, and the actual nomination details are in an attachment, it is best classified as a Report Publication Announcement (RPA) because it is announcing the publication of the shareholder's request, or potentially MANG if the nomination itself is the key event being reported. Given the focus on the nomination process related to the AGM, and the short nature indicating an announcement rather than the full details, RPA is the most appropriate fit based on Rule 2 (Menu vs Meal). If the nomination itself was the primary focus, MANG would be considered, but the text emphasizes the receipt and attachment of the request.
2025-06-24 Polish
Wniosek
AGM Information Classification · 95% confidence The document is a formal letter dated June 4, 2025, from a shareholder (Bogusław Sieczkowski) to the Management Board of Selvita S.A. The subject is the 'zgłoszenia kandydatów do Rady Nadzorczej Spółki' (submission of candidates for the Supervisory Board of the Company). It explicitly references the upcoming Annual General Meeting (Zwyczajne Walne Zgromadzenie) scheduled for June 30, 2025, which includes the election of the Supervisory Board. This action—submitting candidates for board positions ahead of an AGM—is directly related to the governance and composition of the board, which falls under Board/Management Information (MANG) or potentially Governance Information (CGR). However, since it is a direct communication regarding the nomination of a specific individual for the Supervisory Board in anticipation of the AGM elections, it is most closely aligned with management/board composition changes or related preparatory materials. Given the options, MANG (Board/Management Information) is the most appropriate fit for announcing or submitting candidates for the board, although it is a shareholder action, it directly impacts management structure.
2025-06-06 Polish
Zgłoszenie kandydata do Rady Nadzorczej Spółki / Submission of Candidate to the Company's Supervisory Board - Content (PL)
AGM Information Classification · 95% confidence The document text is very short (925 characters) and announces that the Management Board of Selvita S.A. received a nomination for a candidate (Paweł Przewięźlikowski) to the Supervisory Board for the upcoming Annual General Meeting (Zwyczajne Walne Zgromadzenie) scheduled for June 30, 2025. The text explicitly states that the content of the shareholder's request is attached as an appendix ('Treść wniosku akcjonariusza stanowi załącznik do niniejszego raportu'). This structure—a brief announcement referencing an attached document related to a shareholder meeting—strongly suggests this is an announcement about the meeting agenda or related materials, rather than the full AGM presentation itself. Since the core topic is the nomination of a Supervisory Board member, which relates to governance and board structure, it aligns closely with Board/Management Information (MANG) or Governance Information (CGR). However, the context is specifically about a nomination submitted by a shareholder for the upcoming AGM, which is a key component of the materials presented to shareholders before the meeting. Given the options, the nomination of a director candidate is most directly related to Board/Management Information (MANG) or potentially Proxy Solicitation (PSI) if it were soliciting votes, but MANG covers changes/nominations to the board. Since the document is an announcement about a nomination for the board, MANG is the most appropriate fit, although it is short and references an attachment, which could lean towards RPA/RNS. Given the specific content (Board nomination), MANG is prioritized over the general RPA/RNS fallback.
2025-06-06 Polish
Zmiana alokacji zasobów FTE w ramach istotnego zlecenia / Change in FTE Allocation under the Material Order - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a formal notification from the Management Board (Zarząd) of Selvita S.A. regarding a change in the estimated value of a significant contract (Zlecenie) previously announced. The change is substantial (a reduction) and the reason cited relates to the client's financing difficulties. This type of disclosure, detailing a material change in a significant business contract or order value, is typically classified as a significant event announcement. Since it is not a standard financial report (10-K, IR, ER), nor a management change (MANG), nor a director's dealing (DIRS), it fits best under the general category for regulatory announcements that convey material, non-standard information. Given the options, 'Regulatory Filings' (RNS) serves as the best fit for a material, non-standard corporate event disclosure that doesn't match a more specific category like M&A or Capital Change. The document length is short (1210 chars), but it contains the full substance of the announcement, not just a notice to download another report, so RPA is less appropriate than RNS for this specific content type.
2025-06-06 Polish
Powiadomienie
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details transactions (specifically 'Zbycie' - Disposal) involving shares ('akcje') by a person closely associated with a member of the management body ('Tadeusz Wesołowski - Wiceprzewodniczący Rady Nadzorczej'). This structure and content directly correspond to insider dealing reports required under MAR (Market Abuse Regulation). Among the provided definitions, 'Director's Dealing' (Code: DIRS) is the most appropriate classification for reports of personal share transactions by company directors and executives (insider trades).
2025-06-06 Polish
Powiadomienie
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transaction(s) referred to in Article 19(1) of the MAR Regulation). It details transactions (Nabycie/Acquisition) involving shares ('Akcja') by a person closely associated with a management body member (Tadeusz Wesołowski - Vice Chairman of the Supervisory Board) of the issuer (SELVITA SPÓŁKA AKCYJNA). This structure and content—reporting personal share transactions by directors/executives under MAR Article 19—directly corresponds to the definition of Director's Dealing (DIRS).
2025-06-06 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.